Instadose Pharma Corp. (INSD)

Instadose Pharma Income Statement

Financials in millions CAD. Fiscal year is December - November.

Fiscal Year	FY 2021	FY 2020
Period Ending	Nov 30, 2021	Nov 30, 2020
Selling, General & Admin	0.46	0.03
Operating Expenses	0.46	0.03
Operating Income	-0.46	-0.03
Other Non Operating Income (Expenses)	-	0
Pretax Income	-0.46	-0.03
Net Income	-0.46	-0.03
Net Income to Common	-0.46	-0.03
Shares Outstanding (Basic)	75	75
Shares Outstanding (Diluted)	75	75
EPS (Basic)	-0.01	-0.00
EPS (Diluted)	-0.01	-0.00
EBIT	-0.46	-0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.